272 related articles for article (PubMed ID: 31473102)
1. Characterization of Fully Recombinant Human 20S and 20S-PA200 Proteasome Complexes.
Toste Rêgo A; da Fonseca PCA
Mol Cell; 2019 Oct; 76(1):138-147.e5. PubMed ID: 31473102
[TBL] [Abstract][Full Text] [Related]
2. Cryo-EM structures of the human PA200 and PA200-20S complex reveal regulation of proteasome gate opening and two PA200 apertures.
Guan H; Wang Y; Yu T; Huang Y; Li M; Saeed AFUH; Perčulija V; Li D; Xiao J; Wang D; Zhu P; Ouyang S
PLoS Biol; 2020 Mar; 18(3):e3000654. PubMed ID: 32134919
[TBL] [Abstract][Full Text] [Related]
3. The axial channel of the 20S proteasome opens upon binding of the PA200 activator.
Ortega J; Heymann JB; Kajava AV; Ustrell V; Rechsteiner M; Steven AC
J Mol Biol; 2005 Mar; 346(5):1221-7. PubMed ID: 15713476
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the 20S proteasome of the lepidopteran, Spodoptera frugiperda.
Kravchuk OI; Lyupina YV; Erokhov PA; Finoshin AD; Adameyko KI; Mishyna MY; Moiseenko AV; Sokolova OS; Orlova OV; Beljelarskaya SN; Serebryakova MV; Indeykina MI; Bugrova AE; Kononikhin AS; Mikhailov VS
Biochim Biophys Acta Proteins Proteom; 2019 Sep; 1867(9):840-853. PubMed ID: 31228587
[TBL] [Abstract][Full Text] [Related]
5. The Proteasome Activators Blm10/PA200 Enhance the Proteasomal Degradation of N-Terminal Huntingtin.
Aladdin A; Yao Y; Yang C; Kahlert G; Ghani M; Király N; Boratkó A; Uray K; Dittmar G; Tar K
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33233776
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Proteasome Activity Induces Formation of Alternative Proteasome Complexes.
Welk V; Coux O; Kleene V; Abeza C; Trümbach D; Eickelberg O; Meiners S
J Biol Chem; 2016 Jun; 291(25):13147-59. PubMed ID: 27129254
[TBL] [Abstract][Full Text] [Related]
7. Role for proteasome activator PA200 and postglutamyl proteasome activity in genomic stability.
Blickwedehl J; Agarwal M; Seong C; Pandita RK; Melendy T; Sung P; Pandita TK; Bangia N
Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16165-70. PubMed ID: 18845680
[TBL] [Abstract][Full Text] [Related]
8. Differential roles of proteasome and immunoproteasome regulators Pa28αβ, Pa28γ and Pa200 in the degradation of oxidized proteins.
Pickering AM; Davies KJ
Arch Biochem Biophys; 2012 Jul; 523(2):181-90. PubMed ID: 22564544
[TBL] [Abstract][Full Text] [Related]
9. Purification and assay of proteasome activator PA200.
Ustrell V; Pratt G; Gorbea C; Rechsteiner M
Methods Enzymol; 2005; 398():321-9. PubMed ID: 16275339
[TBL] [Abstract][Full Text] [Related]
10. High-resolution cryo-EM proteasome structures in drug development.
Morris EP; da Fonseca PCA
Acta Crystallogr D Struct Biol; 2017 Jun; 73(Pt 6):522-533. PubMed ID: 28580914
[TBL] [Abstract][Full Text] [Related]
11. Cryo-EM reveals the conformation of a substrate analogue in the human 20S proteasome core.
da Fonseca PC; Morris EP
Nat Commun; 2015 Jul; 6():7573. PubMed ID: 26133119
[TBL] [Abstract][Full Text] [Related]
12. Knockout of PA200 improves proteasomal degradation and myelination in a proteotoxic neuropathy.
VerPlank JJ; Gawron JM; Silvestri NJ; Wrabetz L; Feltri ML
Life Sci Alliance; 2024 Apr; 7(4):. PubMed ID: 38320810
[TBL] [Abstract][Full Text] [Related]
13. Proteasome activator 200: the heat is on..
Savulescu AF; Glickman MH
Mol Cell Proteomics; 2011 May; 10(5):R110.006890. PubMed ID: 21389348
[TBL] [Abstract][Full Text] [Related]
14. The cryo-EM structure of the Plasmodium falciparum 20S proteasome and its use in the fight against malaria.
Li H; Bogyo M; da Fonseca PC
FEBS J; 2016 Dec; 283(23):4238-4243. PubMed ID: 27286897
[TBL] [Abstract][Full Text] [Related]
15. Structural Snapshots of 26S Proteasome Reveal Tetraubiquitin-Induced Conformations.
Ding Z; Xu C; Sahu I; Wang Y; Fu Z; Huang M; Wong CCL; Glickman MH; Cong Y
Mol Cell; 2019 Mar; 73(6):1150-1161.e6. PubMed ID: 30792173
[TBL] [Abstract][Full Text] [Related]
16. Proteasome activator PA200 regulates myofibroblast differentiation.
Welk V; Meul T; Lukas C; Kammerl IE; Mulay SR; Schamberger AC; Semren N; Fernandez IE; Anders HJ; Günther A; Behr J; Eickelberg O; Korfei M; Meiners S
Sci Rep; 2019 Oct; 9(1):15224. PubMed ID: 31645612
[TBL] [Abstract][Full Text] [Related]
17. The Proteasome Activator PA200/PSME4: An Emerging New Player in Health and Disease.
Yazgili AS; Ebstein F; Meiners S
Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009043
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for the activation of 20S proteasomes by 11S regulators.
Whitby FG; Masters EI; Kramer L; Knowlton JR; Yao Y; Wang CC; Hill CP
Nature; 2000 Nov; 408(6808):115-20. PubMed ID: 11081519
[TBL] [Abstract][Full Text] [Related]
19. Loss of a 20S proteasome activator in Saccharomyces cerevisiae downregulates genes important for genomic integrity, increases DNA damage, and selectively sensitizes cells to agents with diverse mechanisms of action.
Doherty KM; Pride LD; Lukose J; Snydsman BE; Charles R; Pramanik A; Muller EG; Botstein D; Moore CW
G3 (Bethesda); 2012 Aug; 2(8):943-59. PubMed ID: 22908043
[TBL] [Abstract][Full Text] [Related]
20. Proteasomes and proteasome activator 200 kDa (PA200) accumulate on chromatin in response to ionizing radiation.
Blickwedehl J; McEvoy S; Wong I; Kousis P; Clements J; Elliott R; Cresswell P; Liang P; Bangia N
Radiat Res; 2007 Jun; 167(6):663-74. PubMed ID: 17523843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
